- Shingles and mRNA COVID‐19 vaccine
-
Mungmunpuntipantip R, Wiwanitkit V
- KMID: 2525832
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):292-292.
- doi: 10.7774/cevr.2021.10.3.292
-
- CITED
-
- Close
- SHARE
-
- Close
- Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?
-
Davoodi P, Hashemi A
- KMID: 2525836
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):301-303.
- doi: 10.7774/cevr.2021.10.3.301
-
- CITED
-
- Close
- SHARE
-
- Close
- Challenges managing COVID vaccine-induced immune thrombotic thrombocytopenia in low-middle income countries
-
Ramírez C, Hernández RJS, Durón RM
- KMID: 2525831
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):290-291.
- doi: 10.7774/cevr.2021.10.3.290
-
- CITED
-
- Close
- SHARE
-
- Close
- Parenteral, non-live rotavirus vaccine: recent history and future perspective
-
Song JM
- KMID: 2525814
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):203-210.
- doi: 10.7774/cevr.2021.10.3.203
Since the widespread introduction of oral and live attenuated rotavirus vaccines around the world in 2009, the impacts of disease burden and the effects of disease reduction in developing countries... -
- CITED
-
- Close
- SHARE
-
- Close
- Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study
-
Kang YM, Lim J, Choe KW, Lee KD, Jo DH, Kim MJ, Kim JM, Kim KN
- KMID: 2525829
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):282-289.
- doi: 10.7774/cevr.2021.10.3.282
Purpose This study was conducted to determine differences in adverse events associated with the first and second doses of the BNT162b2 coronavirus disease 2019 vaccine based on the age and sex... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80
-
Burlando M, Herzum A, Cozzani E, Parodi A
- KMID: 2525834
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):298-300.
- doi: 10.7774/cevr.2021.10.3.298
We present the case of a 48-year-old Caucasian woman, who developed an acute urticarial rash after the second dose of coronavirus disease 2019 (COVID-19) vaccination with Oxford-AstraZeneca. Though the most... -
- CITED
-
- Close
- SHARE
-
- Close
- Vaccine usage and wastage in a designated Yellow Fever Vaccination Centre in North India
-
Dkhar SA, Quansar R, Haq I, Salim Khan SM
- KMID: 2525821
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):240-244.
- doi: 10.7774/cevr.2021.10.3.240
Purpose Yellow fever is a viral hemorrhagic fever transmitted through the bite of mosquitoes. World Health Organization guidelines advocate a single dose of vaccine for life-long protective immunity against yellow fever.... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of apolipoprotein A-I and perfluorocarbon emulsion on the production of specific antibodies in mice
-
Zhalimov V, Gritsyna Y, Morenkov O
- KMID: 2525826
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):259-263.
- doi: 10.7774/cevr.2021.10.3.259
Adjuvants are often required to improve the potentially low immunogenicity of vaccines. In this study, it is proposed to use an emulsion based on fluorocarbons as an adjuvant. Since this... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the antigenic stability of influenza virus like particles after exposure to acidic or basic pH
-
Kim SH, Park YC, Song JM
- KMID: 2525824
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):252-258.
- doi: 10.7774/cevr.2021.10.3.252
Purpose Virus-like particles (VLPs) are being developed as a promising vaccine platform and therapeutic delivery. Various strategies for effectively constructing VLPs have been studied, but relatively few studies have been done... -
- CITED
-
- Close
- SHARE
-
- Close
- Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population
-
Lamptey E
- KMID: 2525827
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):264-275.
- doi: 10.7774/cevr.2021.10.3.264
Coronavirus disease 2019 (COVID-19) vaccines undergo rigorous testing in clinical trials to meet high safety standards before rollout to the general population. While over 200 million vaccines are administered in... -
- CITED
-
- Close
- SHARE
-
- Close
- Adverse events following pediatric immunization in an Indian city
-
Paramkusham V, Palakurthy P, Gurram Ns, Talla V, Vishwas HN, Jupally VR, Pattnaik S
- KMID: 2525816
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):211-216.
- doi: 10.7774/cevr.2021.10.3.211
Purpose Adverse effects are noticeable immediately after vaccination, especially when vaccinated to healthy people at the time of vaccination. The vaccine may cause adverse events which are very rare but adverse... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral immunization of rat with chromosomal expression LipL32 in attenuated Salmonella vaccine induces immune respond against pathogenic Leptospira
-
Samakchan N, Thinwang P, Boonyom R
- KMID: 2525817
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):217-228.
- doi: 10.7774/cevr.2021.10.3.217
Purpose Leptospirosis caused by Leptospira spp. remains a global health problem. Available commercial leptospiral vaccines have shown an ineffective prevention for leptospiral infection. The aim of this study was to develop... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?
-
Barsha SY, Haque MMA, Rashid MU, Rahman ML, Hossain MA, Zaman S, Bhuiyan E, Sultana R, Hossian M, Nabi MH, Hawlader MDH
- KMID: 2525833
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):293-297.
- doi: 10.7774/cevr.2021.10.3.293
A 77-year-old man with a past medical history of type 2 diabetes mellitus, peripheral neuropathy, and chronic obstructive pulmonary disease was admitted to the intensive care unit of Bangladesh Medical... -
- CITED
-
- Close
- SHARE
-
- Close
- Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
-
Khanum I, Kumar L, Awan S, Jamil B
- KMID: 2525828
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):276-281.
- doi: 10.7774/cevr.2021.10.3.276
Purpose Considering the cross-protection reported for bacillus Calmette-Guérin (BCG) vaccination on viral respiratory infections, it has been proposed that it could reduce the severity of coronavirus disease 2019 (COVID-19). The objective... -
- CITED
-
- Close
- SHARE
-
- Close
- Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine
-
Shahriari AG, Niazi A, Habibi-Pirkoohi M
- KMID: 2525823
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):245-251.
- doi: 10.7774/cevr.2021.10.3.245
Purpose Newcastle disease (ND) represents a major viral disease across the world which imposes high costs to poultry producers for vaccination. Hemagglutinin-neuraminidase (HN) and fusion (F) proteins are the major immunogenic... -
- CITED
-
- Close
- SHARE
-
- Close
- Staphylococcus aureus derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations
-
Shebl RI, Amer ME, Abuamara TMM, Matar ER, Ahmed HF, Gomah TA, El Moselhy LE, Abu-Elghait M, Mohamed AF
- KMID: 2525819
- Clin Exp Vaccine Res.
- 2021 Sep;10(3):229-239.
- doi: 10.7774/cevr.2021.10.3.229
Purpose One of the essential goals regarding the successful control of rabies infection is the development of a safe, effective, and inexpensive vaccine. the current study aimed to evaluate the inactivation... -
- CITED
-
- Close
- SHARE
-
- Close
